Literature DB >> 8842261

Neurocysticercosis among children in Chicago.

E A Rosenfeld1, S E Byrd, S T Shulman.   

Abstract

Neurocysticercosis has been diagnosed increasingly in the United States as a consequence of increased immigration from and travel to areas of endemic cysticercosis. We report a retrospective series of 47 pediatric cases of neurocysticercosis in our large children's hospital in Chicago, which has a large immigrant population. Neurocysticercosis was diagnosed on the basis of any of the following three criteria: (1) surgical biopsy findings, (2) radiographic findings consistent with neurocysticercosis as well as diagnostic serum and/or cerebrospinal fluid titers, or (3) consistent radiographic findings and a compatible epidemiologic history (without diagnostic serological findings). Epidemiologic, clinical, laboratory, and radiographic data were analyzed. Neurocysticercosis is a relatively common cause of afebrile seizures in children who present to our emergency department in Chicago. Computed tomography and magnetic resonance imaging are both important modalities in evaluation of children with neurocysticercosis. Laboratory studies are neither sensitive for nor predictive of the diagnosis of neurocysticercosis. Therapy is well tolerated. The long-term prognosis for treated patients appears to be excellent.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8842261     DOI: 10.1093/clinids/23.2.262

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  15 in total

1.  Neurocysticercosis and population movements: analysis of 23 imported cases in Spain.

Authors:  C Roca; J Gascón; B Font; T Pujol; M E Valls; M Corachán
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2003-05-29       Impact factor: 3.267

Review 2.  Neurocysticercosis and epilepsy in developing countries.

Authors:  D K Pal; A Carpio; J W Sander
Journal:  J Neurol Neurosurg Psychiatry       Date:  2000-02       Impact factor: 10.154

3.  Serological diagnosis of human cysticercosis by use of recombinant antigens from Taenia solium cysticerci.

Authors:  K Hubert; A Andriantsimahavandy; A Michault; M Frosch; F A Mühlschlegel
Journal:  Clin Diagn Lab Immunol       Date:  1999-07

4.  Cysticercosis-related hospitalizations in the United States, 1998-2011.

Authors:  Kaitlin A O'Keefe; Mark L Eberhard; Shira C Shafir; Patricia Wilkins; Lawrence R Ash; Frank J Sorvillo
Journal:  Am J Trop Med Hyg       Date:  2014-11-10       Impact factor: 2.345

5.  Neurocysticercosis: unraveling the nature of the single cysticercal granuloma.

Authors:  H H García; A E Gonzalez; S Rodriguez; V C W Tsang; E J Pretell; I Gonzales; R H Gilman
Journal:  Neurology       Date:  2010-08-17       Impact factor: 9.910

6.  Neurocysticercosis in radiographically imaged seizure patients in U.S. emergency departments.

Authors:  Samuel Ong; David A Talan; Gregory J Moran; William Mower; Michael Newdow; Victor C W Tsang; Robert W Pinner
Journal:  Emerg Infect Dis       Date:  2002-06       Impact factor: 6.883

Review 7.  Neurocysticercosis in sub-Saharan Africa: a review of prevalence, clinical characteristics, diagnosis, and management.

Authors:  Andrea Sylvia Winkler
Journal:  Pathog Glob Health       Date:  2012-09       Impact factor: 2.894

8.  Influence of gender on cardiac and encephalic inflammation in the elderly with cysticercosis: a case control study.

Authors:  Camila Lourencini Cavellani; Rosana Rosa Miranda Corrêa; Mara Lúcia Fonseca Ferraz; Laura Penna Rocha; Ana Carolina Guimarães Faleiros; Ruy de Souza Lino Junior; Marlene Antônia Dos Reis; Vicente de Paula Antunes Teixeira
Journal:  J Trop Med       Date:  2012-09-26

Review 9.  Clinical manifestations associated with neurocysticercosis: a systematic review.

Authors:  Hélène Carabin; Patrick Cyaga Ndimubanzi; Christine M Budke; Hai Nguyen; Yingjun Qian; Linda Demetry Cowan; Julie Ann Stoner; Elizabeth Rainwater; Mary Dickey
Journal:  PLoS Negl Trop Dis       Date:  2011-05-24

10.  Public health implications of cysticercosis acquired in the United States.

Authors:  Frank Sorvillo; Patricia Wilkins; Shira Shafir; Mark Eberhard
Journal:  Emerg Infect Dis       Date:  2011-01       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.